Navigation Links
Genes Linked to Restless Legs Syndrome Identified
Date:7/14/2011

THURSDAY, July 14 (HealthDay News) -- An international team of researchers has identified two genetic regions that seem to be implicated in restless legs syndrome.

Restless legs syndrome is a condition in which people experience a tingling or "creepy crawly" feeling in the legs, relieved only by movement. One of the most common neurological diseases, the syndrome can lead to chronic sleep loss, daytime fatigue and even depression.

In the new study, scientists from Europe, Canada and the United States analyzed genetic sequence variants in nearly 5,000 people suffering from restless legs syndrome along with more than 7,000 people who did not have the condition.

The researchers found two new genetic regions that play a role in the syndrome. One of the regions is within a gene involved in regulating brain activity, known as TOX3, according to the report published online July 14 in PLoS Genetics.

Although the exact connection between TOX3 and restless legs syndrome remains unclear, it's known that the TOX3 protein protects neuronal cells from death, Juliane Winkelmann, of the Institute of Human Genetics at the University of Technology in Munich, and colleagues noted in a news release from the journal's publisher.

Restless legs syndrome can strike at any age, although it is more common among people aged 65 and older, the study authors noted in the news release.

More information

The U.S. National Institute of Neurological Disorders and Stroke provides more information on restless legs syndrome.

-- Mary Elizabeth Dallas

SOURCE: Public Library of Science, news release, July 14, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Those aching joints could be in your genes
2. Mass. General team identifies new class of antiangiogenesis drugs
3. Telomeres: 2 genes linked to why they stretch in cancer cells
4. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
5. Genes May Control How Long You Look at Happy Faces
6. Advances in delivery of therapeutic genes to treat brain tumors
7. Possible susceptibility genes found in neurodegenerative disorder
8. Penn study identifies genes that may help predict response to BRAF inhibitors for advanced melanoma
9. Scientists identify overactive genes in aggressive breast cancers
10. Genes Tied to Severity of Cystic Fibrosis Identified
11. Outstanding quality of science at 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) underlines conference goal of translating HIV research into practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: